Literature DB >> 2109676

Evaluation of bedside testing options for the critical care unit.

G P Zaloga1.   

Abstract

Bedside testing offers a unique opportunity for earlier and more specific diagnosis, faster and more frequent monitoring, and the opportunity to improve patient care and reduce hospital costs. However, if abused it may not improve patient care and may increase hospital costs. In the future, more clinical studies will need to be performed to determine which tests are cost-effective.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109676     DOI: 10.1378/chest.97.5_supplement.185s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.

Authors:  J T Gilman; P Gal
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

2.  Pro: is continuous intra-arterial blood gas and pH monitoring justifiable?

Authors:  H C Gilbert; J S Vender
Journal:  J Clin Monit       Date:  1996-03

3.  Continuous intra-arterial blood gas monitoring.

Authors:  C K Mahutte
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

4.  Clinical evaluation of a continuous intra-arterial blood gas system in critically ill patients.

Authors:  E E Roupie; L Brochard; F J Lemaire
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

5.  Accuracy of a transcutaneous carbon dioxide pressure monitoring device in emergency room patients with acute respiratory failure.

Authors:  P-E Gancel; E Roupie; L Guittet; S Laplume; N Terzi
Journal:  Intensive Care Med       Date:  2010-11-11       Impact factor: 17.440

6.  Continuous assessment of arterial blood gases.

Authors: 
Journal:  Crit Care       Date:  1997       Impact factor: 9.097

Review 7.  A Review of Biomedical Centrifugal Microfluidic Platforms.

Authors:  Minghui Tang; Guanghui Wang; Siu-Kai Kong; Ho-Pui Ho
Journal:  Micromachines (Basel)       Date:  2016-02-06       Impact factor: 2.891

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.